An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection

  • user warning: Table './intheclinic/cache_filter' is marked as crashed and should be repaired query: SELECT data, created, headers, expire, serialized FROM cache_filter WHERE cid = '1:90ef8d75c19e877794de3374143a8a12' in /persistent/html/includes/cache.inc on line 26.
  • user warning: Table './intheclinic/cache_filter' is marked as crashed and should be repaired query: UPDATE cache_filter SET data = '<p>This study is being conducted to assess the safety and tolerability of an oral liquid solution of Sustiva for antiretroviral therapy-naive or therapy-experienced HIV-1 infected children between the ages 3-16 who are failing or intolerant of current antiretroviral regimen and who are unable to swallow Sustiva capsules.</p>\n', created = 1283570869, expire = 1283657269, headers = '', serialized = 0 WHERE cid = '1:90ef8d75c19e877794de3374143a8a12' in /persistent/html/includes/cache.inc on line 109.
  • user warning: Table './intheclinic/cache_filter' is marked as crashed and should be repaired query: SELECT data, created, headers, expire, serialized FROM cache_filter WHERE cid = '1:4fc1e0ee249ed629e733bc257ed1bb04' in /persistent/html/includes/cache.inc on line 26.
  • user warning: Table './intheclinic/cache_filter' is marked as crashed and should be repaired query: UPDATE cache_filter SET data = '<p>US Sustiva Oral Liquid Expanded Access Program: an Open-Label, Multicenter Expanded Access Study of the Liquid Formulation of Sustiva (Efavirenz, DMP 266)</p>\n', created = 1283570869, expire = 1283657269, headers = '', serialized = 0 WHERE cid = '1:4fc1e0ee249ed629e733bc257ed1bb04' in /persistent/html/includes/cache.inc on line 109.
  • user warning: Table './intheclinic/cache_filter' is marked as crashed and should be repaired query: SELECT data, created, headers, expire, serialized FROM cache_filter WHERE cid = '1:cc7819055cde3194bb3b136bad5cf58d' in /persistent/html/includes/cache.inc on line 26.
  • user warning: Table './intheclinic/cache_filter' is marked as crashed and should be repaired query: UPDATE cache_filter SET data = '<p>&nbsp;</p>\n', created = 1283570869, expire = 1283657269, headers = '', serialized = 0 WHERE cid = '1:cc7819055cde3194bb3b136bad5cf58d' in /persistent/html/includes/cache.inc on line 109.
  • user warning: Table './intheclinic/cache_filter' is marked as crashed and should be repaired query: SELECT data, created, headers, expire, serialized FROM cache_filter WHERE cid = '1:48109b13475da891012ba13801fa95ea' in /persistent/html/includes/cache.inc on line 26.
  • user warning: Table './intheclinic/cache_filter' is marked as crashed and should be repaired query: UPDATE cache_filter SET data = '<p>Inclusion Criteria:\n<ul>\n<li>Children 3-16 years of age</li>\n<li>Anti-retroviral naive or experienced</li>\n<li>Failing or intolerant to current Anti-retroviral regimen</li>\n<li>Limited available viable therapeutic options</li>\n<li>Inability to take capsules/tablets</li>\n</ul>\n</p><p> Exclusion Criteria:\n<ul>\n<li>Less than 10kg</li>\n<li>Failure on or concomitant use of other NNRTIs</li>\n<li>An active AIDS-defining opportunistic infection or disease</li>\n<li>More than two episodes of moderate to severe diarrhea or vomiting lasting more than four days within the past three months</li>\n</ul>\n</p>', created = 1283570869, expire = 1283657269, headers = '', serialized = 0 WHERE cid = '1:48109b13475da891012ba13801fa95ea' in /persistent/html/includes/cache.inc on line 109.

This study is being conducted to assess the safety and tolerability of an oral liquid solution of Sustiva for antiretroviral therapy-naive or therapy-experienced HIV-1 infected children between the ages 3-16 who are failing or intolerant of current antiretroviral regimen and who are unable to swallow Sustiva capsules.

Background information
Trial ID: 
NCT00162227
Other unique IDs: 
AI266-913
Official title: 

US Sustiva Oral Liquid Expanded Access Program: an Open-Label, Multicenter Expanded Access Study of the Liquid Formulation of Sustiva (Efavirenz, DMP 266)

Detailed description: 

 

Number to be enrolled: 
0 patients
Clinical information
Age groups: 
Child
Gender: 
Both
Eligibility criteria: 

Inclusion Criteria:

  • Children 3-16 years of age
  • Anti-retroviral naive or experienced
  • Failing or intolerant to current Anti-retroviral regimen
  • Limited available viable therapeutic options
  • Inability to take capsules/tablets

Exclusion Criteria:

  • Less than 10kg
  • Failure on or concomitant use of other NNRTIs
  • An active AIDS-defining opportunistic infection or disease
  • More than two episodes of moderate to severe diarrhea or vomiting lasting more than four days within the past three months

Interventions: 
Efavirenz
Conditions treated: 
HIV Infection
Funding
Funding types: 
INDUSTRY
Sponsor: 
Bristol-Myers Squibb
Dates
Date the data was first received: 
Fri, 2005-09-09
Trial start date: 
Fri, 2000-09-01
Trial completion date: 
Wed, 2010-12-01
Trial last updated: 
Wed, 2009-05-20